5 completed. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Schizophreniform Disorders: new trials by email Literature Review of Schizophreniform Disorders trials Research Report on Schizophreniform Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) BXCL501, Matching Placebo - Agitation,Psychomotor, Bipolar I Disorder | Phase 3 | Completed | BioXcel Therapeutics Inc | 452 | 2022-11-21 | 2026-08-07 |
| Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia Sublingual film containing dexmedetomidine (BXCL501), Placebo Film - Agitation, Schizophrenia | Phase 3 | Completed | BioXcel Therapeutics Inc | 380 | 2020-01-24 | 2026-08-11 |
| Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder ALKS 3831, Olanzapine - Schizophrenia, Schizophreniform Disorders | Phase 3 | Completed | Alkermes, Inc. | 426 | 2017-06-08 | 2023-01-19 |
| Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder Estradiol, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Completed | Tangent Data | 209 | 2015-12-04 | 2020-05-22 |
| Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants Ethyl-eicosapentaenoic acid (EPA), Vitamins E + C, Etyl EPA (placebo) - Schizophrenia, Schizophreniform Disorders | Phase 2 / Phase 3 | Completed | University Hospital, Aker | 99 | 2001-09-01 | 2011-01-04 |
Psychotic Disorders (5) · Schizophrenia (5) · Psychomotor Agitation (2) · Bipolar Disorder (1) · Delusions (1) · Hallucinations (1) · Hypertriglyceridemia (1)
Mental Disorders (5) · Schizophrenia Spectrum and Other Psychotic Disorders (5) · Behavior (3) · Behavioral Symptoms (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Aberrant Motor Behavior in Dementia (2) · Dyskinesias (2) · Psychomotor Disorders (2) · Bipolar and Related Disorders (1) · Dyslipidemias (1) · Hyperlipidemias (1)
Dexmedetomidine (2) · Estradiol (1) · Olanzapine (1) · eicosapentaenoic acid ethyl ester (1)
BioXcel Therapeutics Inc (2) · Alkermes, Inc. (1) · Tangent Data (1) · University Hospital, Aker (1)
United States (3) · Austria (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1) · Moldova (1) · Norway (1) · Poland (1) · Russia (1) · South Korea (1) · Spain (1) · Ukraine (1) · United Kingdom (1)
BioXcel MM (1) · BioXcel MM, MD (1) · Paull G Radu, M.D. (1)